scholarly journals Building Infectious Disease Research Programs to Promote Security and Enhance Collaborations with Countries of the Former Soviet Union

2015 ◽  
Vol 3 ◽  
Author(s):  
James C. Bartholomew ◽  
Andrew D. Pearson ◽  
Nils Chr. Stenseth ◽  
James W. LeDuc ◽  
David L. Hirschberg ◽  
...  
2021 ◽  
Vol 6 (1) ◽  
Author(s):  
Hee-Gyeong Yi ◽  
Hyeonji Kim ◽  
Junyoung Kwon ◽  
Yeong-Jin Choi ◽  
Jinah Jang ◽  
...  

AbstractRapid development of vaccines and therapeutics is necessary to tackle the emergence of new pathogens and infectious diseases. To speed up the drug discovery process, the conventional development pipeline can be retooled by introducing advanced in vitro models as alternatives to conventional infectious disease models and by employing advanced technology for the production of medicine and cell/drug delivery systems. In this regard, layer-by-layer construction with a 3D bioprinting system or other technologies provides a beneficial method for developing highly biomimetic and reliable in vitro models for infectious disease research. In addition, the high flexibility and versatility of 3D bioprinting offer advantages in the effective production of vaccines, therapeutics, and relevant delivery systems. Herein, we discuss the potential of 3D bioprinting technologies for the control of infectious diseases. We also suggest that 3D bioprinting in infectious disease research and drug development could be a significant platform technology for the rapid and automated production of tissue/organ models and medicines in the near future.


Science ◽  
2015 ◽  
Vol 349 (6252) ◽  
pp. 1259504-1259504 ◽  
Author(s):  
P. T. J. Johnson ◽  
J. C. de Roode ◽  
A. Fenton

2019 ◽  
Vol 20 (6) ◽  
pp. 323-340 ◽  
Author(s):  
Maria A. Spyrou ◽  
Kirsten I. Bos ◽  
Alexander Herbig ◽  
Johannes Krause

2019 ◽  
Vol 6 (1) ◽  
Author(s):  
Şenay Kafkas ◽  
Marwa Abdelhakim ◽  
Yasmeen Hashish ◽  
Maxat Kulmanov ◽  
Marwa Abdellatif ◽  
...  

2020 ◽  
Vol 3 (1) ◽  
pp. 43-59
Author(s):  
Peter M. Kasson

Infectious disease research spans scales from the molecular to the global—from specific mechanisms of pathogen drug resistance, virulence, and replication to the movement of people, animals, and pathogens around the world. All of these research areas have been impacted by the recent growth of large-scale data sources and data analytics. Some of these advances rely on data or analytic methods that are common to most biomedical data science, while others leverage the unique nature of infectious disease, namely its communicability. This review outlines major research progress in the past few years and highlights some remaining opportunities, focusing on data or methodological approaches particular to infectious disease.


Sign in / Sign up

Export Citation Format

Share Document